Dialysis Data

The Dialysis Facility Compare (DFC) website is a public website that has detailed information about dialysis facilities certified by Medicare.  The Centers for Medicare and Medicaid Services (CMS) makes quality measures available to the general public on the DFC website.  These quality measures come from the Dialysis Facility Reports and Quarterly Dialysis Facility Compare (QDFC) Reports.  Facilities are allowed to preview their DFC quality measure prior to public reporting. These reports are available for dialysis facilities for preview on the DialysisData.org website.  Once the preview period closes, the measures are displayed on Medicare's Dialysis Facility Compare website.

The quality measures on the DFC website are updated quarterly in January, April, July, and October. Medicare-certified dialysis facilities active anytime during the four-year reporting period will receive a DFR. Facilities certified on or after January 1 of the current year will not receive a report.

USRDS 2020 INTERACTIVE ANNUAL DATA REPORT

The Chronic Disease Research Group (CDRG), in partnership with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is proud to announce the next evolution of the United States Renal Data System (USRDS) Annual Data Report (ADR): The 2020 interactive ADR (https://adr.usrds.org/2020). For the first time in the history of the USRDS, the ADR is fully interactive. Through intuitive, easy-to-use navigation, website users can sort through the volume chapters, customize data representation, and download the tailored information in common data formats.

Important findings in this year's Annual Data Report include:

  • A 14.9% prevalence of CKD among U.S. adults
  • A death rate more than twice as high in people with versus without CKD
  • A 40% increase in hospitalizations with acute kidney injury from 2009 to 2018 and a persistently large disparity in acute kidney injury between black and white patients
  • An increase of only 0.2% in the adjusted rate of end-stage renal disease (ESRD) incidence from 2017 to 2018
  • Strong growth in home dialysis use and preemptive kidney transplant
  • A declining ultrafiltration rate in patients undergoing hemodialysis
  • Lack of progress in catheter use at dialysis initiation, as well as hospitalization and readmission of dialysis patients, but a 1.5% decrease in the death rate of dialysis patients from 2017 to 2018
  • All-time highs in kidney transplants and graft survival among deceased donor transplants
  • Steadily decreasing use of prescription opioids among CKD and ESRD patients from 2009 to 2018
  • 23.2% of Medicare fee-for-service spending in patients with CKD and ESRD and continued growth of Medicare Advantage enrollment of dialysis patients

Contacts

Jaya Bhargava, Ph.D., CPHQ
Regional Operations Director
(203) 285-1215
jaya.bhargava@ipro.us

Jasmine Taborn
Data Coordinator
(919) 463-4522
jasmine.taborn@ipro.us